The US Food and Drug Administration on Thursday approved Gilead Sciences Inc's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States.

Remdesivir gets US FDA approval for hospitalized COVID-19 patients

The Mongolian health ministry has requested for Remdesivir from Indian companies, India's envoy to Mongolia M P Singh has said. Remdesivir though still experimental holds promise in treatment for COVID.

Mongolia requests for Remdesivir used COVID treatment from Indian companies

Remdesivir, an antiviral drug doubted as potential COVID-19 cure has failed in its first clinical trial in the United States of America.

Remdesivir, an antiviral drug doubted as potential COVID-19 cure, failed in first clinical trial